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Purpose: Flow‐compensated (FC) diffusion‐weighted MRI (DWI) for 
intravoxel‐incoherent motion (IVIM) modeling allows for a more detailed descrip-
tion of tissue microvasculature than conventional IVIM. The long acquisition time of 
current FC‐IVIM protocols, however, has prohibited clinical application. Therefore, 
we developed an optimized abdominal FC‐IVIM acquisition with a clinically feasi-
ble scan time.
Methods: Precision and accuracy of the FC‐IVIM parameters were assessed by fit-
ting the FC‐IVIM model to signal decay curves, simulated for different acquisition 
schemes. Diffusion‐weighted acquisitions were added subsequently to the proto-
col, where we chose the combination of b‐value, diffusion time and gradient profile 
(FC or bipolar) that resulted in the largest improvement to its accuracy and preci-
sion. The resulting two optimized FC‐IVIM protocols with 25 and 50 acquisitions 
(FC‐IVIMopt25 and FC‐IVIMopt50), together with a complementary acquisition con-
sisting of 50 diffusion‐weighting (FC‐IVIMcomp), were acquired in repeated abdomi-
nal free‐breathing FC‐IVIM imaging of seven healthy volunteers. Intersession and 
intrasession within‐subject coefficient of variation of the FC‐IVIM parameters were 
compared for the liver, spleen, and kidneys.
Results: Simulations showed that the performance of FC‐IVIM improved in tis-
sue with larger perfusion fraction and signal‐to‐noise ratio. The scan time of the 
FC‐IVIMopt25 and FC‐IVIMopt50 protocols were 8 and 16 min. The best in vivo per-
formance was seen in FC‐IVIMopt50. The intersession within‐subject coefficients of 
variation of FC‐IVIMopt50 were 11.6%, 16.3%, 65.5%, and 36.0% for FC‐IVIM model 
parameters diffusivity, perfusion fraction, characteristic time and blood flow veloc-
ity, respectively.
Conclusions: We have optimized the FC‐IVIM protocol, allowing for clinically fea-
sible scan times (8‐16 min).
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1 |  INTRODUCTION
Capillary perfusion plays a large role in many major diseases, 
including cancer, and is prognostic for many indications.1,2 
MRI offers several approaches to assessing perfusion, of 
which the intravoxel incoherent motion (IVIM) model fit to 
diffusion‐weighted MRI (DWI) data is a promising exam-
ple without contrast injection. The IVIM model is a two‐ 
compartment model for DWI,3 in which signal decay is 
described by a tissue compartment and a perfusion com-
partment. The latter describes incoherent motion, which is 
often attributed to blood flow, but can also be related to other 
sources.4
Almost all IVIM studies assume the pseudo‐diffusion limit 
of the IVIM model, which requires the diffusion time (T) to 
be several times larger than the characteristic time scale (τ) of 
the capillary perfusion.3 In this limit, IVIM is described by a 
bi‐exponential signal decay, with a diffusion coefficient (D), 
pseudo‐diffusion coefficient (D*), and perfusion fraction (f). 
This bi‐exponential IVIM model was used to characterize 
lesions and monitor treatment response in several studies.5-7 
However, accurate and precise characterization of IVIM re-
mains challenging, because the estimated values of the IVIM 
parameters depend on acquisition settings8 and show large 
day‐to‐day variations.9,10
In the past,11-13 it was shown that the assumption of the 
pseudo‐diffusion limit (T∕𝜏 <7) is not necessarily valid in 
abdominal organs and the bi‐exponential signal description 
is thus inappropriate. This could partially explain the poor 
reproducibility of f and D*, and f 's recently reported depen-
dency on blood flow speed.14 To overcome these limitations 
of conventional IVIM, the flow‐compensated (FC) IVIM 
model was suggested.13 In addition to assessing D and f, 
FC‐IVIM also models microvasculature with blood flow ve-
locity (v) and vessel length (l) which are connected through 
the characteristic time scale 휏 = l∕v. While in conventional 
IVIM those are combined into D∗ = lv∕6, FC‐IVIM allows as-
sessing these additional perfusion‐related parameters, which 
might be prognostic and predictive for treatment response, 
separately.
However, fitting the FC‐IVIM model and assessing these 
microvascular parameters requires additional DWI measure-
ments with FC gradients and at different T. Adding those 
measurements substantially increases the scan time of the 
already long IVIM acquisition, rendering clinical application 
unfeasible. For example, the protocol of Wetscherek et al13 
consisted of 20 breath‐holds of 37.5 s each. In the past, con-
ventional IVIM has successfully been optimized,15-17 render-
ing substantially shorter scan protocols; however, there is no 
guideline to what acquisitions are most important regarding 
FC‐IVIM.
Therefore, the aim of this work was to develop and test 
a clinically feasible acquisition protocol for FC‐IVIM in the 
abdomen by selecting the most informative combinations 
of b, T, and gradient profile to enable accurate and precise 
FC‐IVIM DWI. We achieved this by a simulation study, 
followed by in vivo validation in healthy volunteers. The 
resulting optimized protocol facilitates the study of the added 
clinical benefit of FC‐IVIM.
2 |  METHODS
All data were analyzed in Matlab 2018a (MathWorks, 
Natick, MA). Figures were created using Matlab and PRISM 
8.0 (GraphPad Software, San Diego, CA). The published 
FC‐IVIM toolbox13 was used (downloaded from https ://
github.com/awets chere k/ivim_tools ) for FC‐IVIM mod-
eling and data fitting. Early results from part of this work 
were presented at the 2018 Joint Annual ISMRM/ESMRMB 
Meeting.18
2.1 | FC‐IVIM model fitting
We used the following FC‐IVIM model:
with
Here, S represents the diffusion‐weighted signals, S0 the 
signal without diffusion‐weighting, D the diffusion coef-
ficient, f the perfusion fraction, v the blood flow velocity, 
τ the characteristic timescale, β the encoding gradient shape 
(β = 0 for bipolar, β = 1 for FC), T the diffusion time, ρ the 
normalized phase distribution for β and the average num-
ber of traversed vessel segments =T∕휏, and φ the normal-
ized phase. Db,bipolar and Db,FC are the apparent diffusion 
coefficients of blood for bipolar and FC gradients, respec-
tively, which we set to values of Db,bipolar = 1.30 mm2/s and 
Db,FC = 1.54 mm2/s as suggested in literature.19 The sig-
nal attenuation F(b, T, β, τ, v) was calculated numerically 
using the normalized phase distributions included in the 
FC‐IVIM toolbox.13
The model was fitted simultaneously to signal from both 
FC and non‐FC bipolar measurements with T and b‐values 
(1)
S (b, T , 훽)=S0 ⋅
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using a least squares fit (Matlab’s lsqnonlin function). The 
model's fit parameters were D, f, v, τ, and the nuisance pa-
rameter S0. Unless mentioned otherwise, fit constraints were 
set to 0.5 × 10−3 < D < 3.0 × 10−3 mm2/s, 0 < f < 60%, 20 < 
τ < 500 ms, 0.2 < v < 15 mm/s.
Per voxel, the signal was normalized to the mean 
S(b = 0 mm2/s) signal. Initially, a mono‐exponential fit was 
performed to the high b‐values (b ≥ 150 mm2/s), of the bipo-
lar gradient data. D and f from these fits were used to initial-
ize D and f from the full FC‐IVIM fit. Further fit parameters 
were initialized with S0 = 1, τ = 200 ms, and v = 4 mm/s.
2.2 | Simulations
Two sets of simulations were performed. The first deter-
mined the best acquisition strategy. The second inves-
tigated the influence of signal‐to‐noise ratio (SNR) and 
perfusion fraction on the accuracy and precision of the 
estimated FC‐IVIM parameters. In both cases, data were 
simulated using the FC‐IVIM model equation (Equation 1). 
Rician noise was added according to the desired SNR and 
the FC‐IVIM model was fit to the noisy data. We simulated 
six repeated acquisitions to represent acquisitions from dif-
ferent diffusion directions. These acquisitions were aver-
aged before fitting.
2.3 | Optimal acquisition strategy
The optimal acquisition strategy was determined iteratively 
using an approach similar to Lemke et al,15 by repetitively 
adding the most informative acquisition to the set. A mini-
mum of five acquisitions is required to fit FC‐IVIM, which 
has five independent variables (S0, D, f, τ, and v); hence, we 
manually selected the first five acquisition points (red ×'s in 
F I G U R E  1  Color coded (dark blue‐yellow, 0‐3 repeated acquisitions) acquisition settings of T‐value (vertical axis), b‐value (horizontal 
axis), and flow compensation (vertical axis) for four acquisition schemes. Black regions were not accessible on our MR scanner. Images depict 
the optimal acquisitions when adding 20 (top left) or 45 measurements (top right) to the preselected 5 (red crosses) and the 50 acquisitions of the 
complementary set (bottom). The order in which measurements were added is provided in Supporting Information Table S1
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Figure 1). Then, we iteratively determined the next most in-
formative (b, T, β) data point to add to the acquisition: given 
an optimal set of N‐1 acquisitions, the optimal Nth acquisi-
tion was determined by simulating every possible acquisition 
5000 times, and selecting the acquisition that minimized the 
normalized errors, as detailed below. For these simulations, 
tissue properties were randomly selected from a predefined 
range comprising typical abdominal values: D = 1‐2 × 10−3 
mm2/s, f = 10‐40%, τ = 20‐500 ms and v = 1‐10 mm/s. 
Furthermore, Rician noise was added at an effective SNR of 
20 at b = 0 s/mm2. Considering a range of values for the ground 
truth parameters prevented the optimal set to be specific to a 
single parameter combination. The 5000 randomly selected 
model parameter sets were kept the same for each tested Nth 
acquisition and drawn again for selecting the N+1th one.
Only b and T combinations that could be experimentally 
realized on our MRI scanner were tested (nonblack regions 
in Figure 1). To avoid confounding effects of T2 relaxation,20 
we chose to keep the echo‐time constant (determined by 
maximum T). While increasing the maximum T is desirable 
from a modeling perspective, the consequential increase 
in TE will reduce the SNR of every measurement due to 
T2‐relaxation. Therefore, we limited the range of diffusion 
times toTmax = 100 ms. Values of T lower than Tmin = 40 
ms were not feasible with our hardware. Based on previously 
published results,13 we assumed that the effect of T was small 
for bipolar gradients and we increased the step size for T to 
reduce simulation time. The b‐values ranged from 0 to what 
was achievable with our gradient set for that given T (Figure 
1). As most of the flow‐related changes occur at lower b‐val-
ues, we used smaller step‐sizes for lower b‐values.
The FC‐IVIM model was fitted to all simulated datasets 
with constraints: 0 < D < 4.0 × 10−3 mm2/s, 0 < f < 100%, 
1 < τ < 1000 ms, 0 < v < 20 mm/s). The cost function was 
determined per added combination of (b, T, β):
with
Here, n represents the nth experiment and is summed over 
the 5000 repeats, θ can be D, f, τ, and v; θerror,n represents 
the estimated error in the parameter for the nth experiment; 
and θtrue,n and θfit,n represent the true and estimated values 
for the nth experiment (for D, f, τ, and v). The errors were 
normalized by dividing them by θnorm, which represents 
the mean parameter value of the interval that the parameter 
was drawn from (Dnorm = 1.5 × 10−3 mm2/s, fnorm = 25%, 
τnorm = 260 ms, and vnorm = 5.5 mm/s). The acquisition with 
the smallest mean overall loss was deemed most informative 
and added as the next measurement. This procedure was re-
peated 45 times, resulting in selecting the optimal 45 (+5 ini-
tial) acquisition points.
The performance of FC‐IVIM at each added acquisition 
was simulated a second time using a new random selection 
of simulation parameters to prevent performance bias by 
selection of acquisition with minimal error. These simula-
tions used the new, earlier mentioned fit constraints. The 
error per parameter, θerror,n, was calculated using Equation 4. 
The 5, 25, 50, 75, and 95 percentiles of θerror,n were plotted 
to study the relation between acquisition time and expected 
error.
2.4 | Minimum SNR and f
To accurately estimate the FC‐IVIM model parameters de-
scribing the vasculature (f, τ, and v), sufficient SNR and 
blood signal (f) needs to be present. Hence, simulations 
were done to investigate the relation between SNR and f, 
and the accuracy and precision of the estimated FC‐IVIM 
parameters. The optimal 50 acquisitions from the previous 
simulations (Figure 1, top right) were used as simulated ac-
quisition protocol. For both simulation series, 1 parameter 
was varied (SNR: 10‐60; f: 3‐50%) while having the rest set 
to literature values13: D = 1.88 × 10−3 mm2/s, f = 28.7%, 
τ = 224 ms, and v = 3.91 mm/s for pancreas and D = 1.12 × 
10−3 mm2/s, f = 34.7%, τ = 144 ms, and v = 4.60 mm/s 
for liver. SNR was set to 20 for the simulations varying f. 
Simulations of fits were repeated 5000 times while adding 
new random noise each time. The fit error was determined 
as defined in Equation 4, with 휃norm=휃true,n=휃true. These 
simulations were repeated with a manually selected set of 
50 complementary (b, T, β) values (Figure, 1 bottom), to 
highlight the gain from selecting an optimized acquisition 
scheme over a naive one. The 5, 25, 50, 75, and 95 percen-
tiles of 휃error,n were plotted.
2.5 | In vivo measurements
Abdominal DWI images of seven healthy volunteers (three 
female, four male; aged 21‐28 years old) were obtained 
between August and November 2018 using a 1.5T scanner 
(Magnetom Aera, Siemens Healthineers) at the University 
Hospital Erlangen. The local ethics committee of the 
University Hospital Erlangen approved volunteer scanning 
and all volunteers gave written informed consent. Scans were 
obtained with a 30‐channel anterior body coil and 32‐channel 
posterior coil in the table. The scanner was equipped with 
XQ gradients (Gmax = 45 mT/m, Smax = 200 mT/m/ms). The 
DWI acquisitions were repeated during the first session to 
enable assessment of intrasession repeatability, and a second 
session was held 7 days (median, 7 days; range, 6‐14 days) 
(3)cost= 1
5000
5000∑
n=1
√
1
4
(
D2
error,n
+ f 2
error,n
+휏2
error,n
+v2
error,n
)
,
(4)휃error,n=100% ⋅
휃true,n−휃fit,n
휃norm
.
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later to enable the assessment of intersession repeatability. 
While the intrasession repeatability characterizes short‐term 
accuracy, the intersession repeatability additionally accounts 
for day‐to‐day and setup‐related variation.
DWI data were acquired during free breathing, without 
motion management, using a diffusion‐weighted single‐shot 
echo planar imaging read‐out. The acquisition consisted of 
six 8‐mm‐thick slices, acquired in descending order, with 
8‐mm slice gap to prevent inflow of recently exited blood from 
neighboring slices. Field of view was 284 × 350 mm2, with 2.7 
× 2.7 mm2 voxel size. Other settings were: repetition time = 
3000 ms; echo time = 122 ms; partial Fourier factor = 6/8; and 
acceleration factor = 2 (GRAPPA, 24 reference lines); SPAIR 
fat suppression; bandwidth 1775 Hz/pixel; diffusion gradients 
were applied simultaneously on two gradient axes along six 
directions (multi‐directional diffusion weighting: [1, 1, 0], 
[1, −1, 0], [1, 0, 1], [1, 0, − 1], [0, 1, 1], and [0, 1, − 1]). The ac-
quisition consisted of the five base (b, T, β) values (red crosses 
in Figure 1), the 45 most informative (b, T, β) values according 
to the simulations (Figure 1, top right), and an acquisition of 50 
manually selected complementary (b, T, β) values (Figure 1, 
bottom). To make implementation easier, the optimal acquisi-
tion set was limited to T = 40, 70, and 100 ms and the seven 
measurements of other T were moved to the closest acquired 
T (Supporting Information Table S1, which is available online, 
gives the implemented acquisition). Acquisition of the sets 
took 32 min each (optimized and complementary), resulting in 
a scan time of 64 min for the first session, which included one 
repetition and 32 min for the second session.
2.6 | Signal preprocessing
Per DWI dataset, for each slice, a 2D+temporal principal 
component analysis (PCA) based groupwise image regis-
tration21 was performed in Elastix22 to register the images 
from the different sets and (b, T, β)‐values to each other. 
For contouring one purposes, registered images were de-
noised using PCA23 followed by maximum intensity pro-
jection over the six acquisition directions24 (using the PCA 
denoising method from Gurney‐Champion et al23). A re-
searcher with six years of experience in abdominal imaging 
(O.J.G.) then contoured the liver, spleen, and both kidneys 
on all slices that were within the acquired field of view for 
both imaging sessions. The regions of interest (ROIs) were 
propagated to the repeated intersession and intrasession 
images using rigid image registration and updated manu-
ally where required. ROIs had a median size (range) of 
4592 (2590‐6032) voxels, 945 (344‐1360), 733 (488‐987), 
and 437 (301‐718) voxels for the liver, spleen, left kidney, 
and right kidney, respectively.
Due to the long acquisitions, potentially signal drifts oc-
curred as a result of, e.g., gradient heating.25 Hence, per con-
tour, all acquisitions with b = 0 s/mm2 and their corresponding 
acquisition times were selected and Matlab’s fitlm was used 
to detect potential drifts in the mean signal intensity from 
that ROI. The function returned an offset, a, and slope, b. 
If the slope was significantly nonzero (P < 0.05), the data 
from that ROI was corrected accordingly, (assuming linear 
scaling) using
Here, Scorrected is the corrected signal and Sold the original 
signal.
2.7 | Analysis
Four FC‐IVIM fits were performed to the median signal 
decay in each ROI using the measurements at (I) the 5 base 
+ 20 optimized measurements, (II) the 5 base + 45 opti-
mized measurements, (III) the 50 complementary measure-
ments and (IV) all 100 measurements combined, which we 
will call FC‐IVIMopt25, FC‐IVIMopt50, FC‐IVIMcomp, and 
FC‐IVIM100, respectively. Organ‐specific fit constraints, as 
described in Table 1, were used. Fit quality was assessed by 
the within‐subject coefficient of variation (wCV) for the re-
peated measures. More stable measurements, at informative 
(b, T, β) are expected to be more precise and, hence, have a 
lower wCV.
Another quantity assessing data reliability from repeated 
measurements is the two‐way mixed effects, absolute agree-
ment, multiple measurements intraclass correlation coef-
ficient (ICC).26,27 We calculated the wCV and ICC for the 
optimal acquisition scheme (FC‐IVIMopt50). ICC values of 
above 0.75 were considered to have good reliability.
In vivo, the ground truth is unknown. By assuming that 
the FC‐IVIM100 data, which contains all measured (b, T, β) 
combinations, allows for the best estimate of the true param-
eters, the bias of the other acquisition schemes can be esti-
mated by taking the mean of the normalized difference:
Here, 휃IVIM100,m and 휃IVIMopt50,m are the parameters (D, f, τ, 
and v) of FC‐IVIM100 and FC‐IVIMopt50 from the mth 
(5)Scorrected (t)=
Sold (t)
a+b ⋅ t
(6)bias휃 =100% ⋅
1
M
M∑
m=1
휃FC−IVIM100,m−휃FC−IVIMopt50,m
휃FC−IVIM100,m
.
T A B L E  1  Organ‐specific fit constraints
Liver Spleen Kidneys
Min Max Min Max Min Max
D (10−3 mm2/s) 0.6 2.5 0.5 1.5 1.0 3.0
f (%) 20 80 5 25 10 35
τ (ms) 20 500 50 300 20 500
v (mm/s) 0.2 12 0.2 12 3 15
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volunteer and M the total number of volunteer measurements. 
This was repeated for IVIMcomp, where 휃FC−IVIMopt50,m is re-
placed by 휃FC−IVIMcomp,m in Equation 6.
3 |  RESULTS
3.1 | Simulations
Figure 1 illustrates the initial 20 and 45 selected measure-
ments, whereas Supporting Information Table S1 shows the 
order in which the measurements were added. In general, 
several measurements were added at high T (100 ms) with 
midrange b‐values (60‐150 s/mm2) for the FC gradients, 
whereas for bipolar gradients low b‐values were preferred 
(0‐30 s/mm2). These simulations took two months running 
on 5 cores of a 3.5 GHz Intel Core i7‐4771.
Figure 2 illustrates how the errors decreased as a function 
of the number of selected optimal acquisitions. The plotted 
red and orange lines show that the reduction was roughly pro-
portional to √N. We found that the largest error reduction 
occurred within the first 25 measurements. However, increas-
ing the number of acquisitions from 25 to 50 did still substan-
tially decrease the error and would be desired if measurement 
time was available.
At optimal settings, simulated tissue with larger f gave 
substantial smaller errors in f, v and τ, whereas the error in 
D increased slightly. All errors decreased as a function of 
SNR (Figure 3). The behaviors above were similar for both 
simulated datasets (pancreas and liver), which suggests this 
is a general trend. IVIMopt50 (Figure 3, gray shades) outper-
formed IVIMcomp (Figure 3, orange and red dashed lines) 
consistently. The graph demonstrated, for example, that for 
the liver, at an SNR of 20, we expect to estimate D, f, v, and 
τ with the 5%‐95% percentiles at boundaries −8.4%‐5.9%, 
−6.1%‐6.2%, −10.5%‐10.2%, and −9.4%‐10.6% for 
IVIMopt50. For IVIMcomp, these boundaries are considerably 
broader, at −15.8%‐10.2%, −7.4%‐10.0%, −29.9%‐26.2%, 
and −35.9%‐44.8%.
3.2 | In vivo
Figure 4 illustrates the image quality of the processed data 
and delineated ROIs from a representative volunteer. Figure 5 
shows typical fits of the FC‐IVIM model to ROI‐averaged 
data. Exemplary fits for each organ at optimal settings (liver, 
spleen, and kidneys using FC‐IVIMopt50) are displayed to 
highlight the variety in signal decays. Furthermore, the 
data from different acquisition approaches (FC‐IVIMopt25, 
FC‐IVIMopt50, FC‐IVIM100, and FC‐IVIMcomp for the liver) 
are shown for the liver. Table 2 reports the median (over 
different organs) intersession and intrasession wCVs of the 
FC‐IVIM parameters for the different imaging approaches 
and illustrates that FC‐IVIMopt50 performs best compared 
with the similarly long FC‐IVIMcomp acquisition.
Supporting Information Table S2 reports the inter-
session and intrasession wCVs for all ROIs. FC‐IVIM100 
(32‐min acquisition) had the highest precision, with in-
tersession wCV lower than wCV of FC‐IVIMopt50 in 11 of 
16 comparisons (4 organs × 4 parameters). FC‐IVIMopt50 
showed the best results of all protocols obtainable within 
16 min. FC‐IVIMopt50 had a lower intersession wCV than 
FC‐IVIMcomp for 14 of 16 comparisons and had lower inter-
session wCV than FC‐IVIMopt25 for 12 of 16 comparisons. 
The intersession wCVs of FC‐IVIMopt50 were on average 
F I G U R E  2  The error of D, f, τ, and 
v as a function of the number of optimized 
acquisitions. The 5%‐95% interval (light 
gray), 25%‐75% (dark gray) interval, 
and median value of the 5000 repeated 
simulations are plotted. The corresponding 
asymptotic 
√
N limit is displayed in orange 
and red, respectively, where N denotes the 
number of acquisitions
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29% lower than the intersession wCV of FC‐IVIMcomp 
[100% × 2 × (wCVcomp−wCVopt50)/ (wCVcomp+wCV opt50)] 
and 23% lower than IVIMopt,25. The intersession wCVs of 
FC‐IVIM100 (32‐min acquisition) were on average 19% 
lower than the wCV of FC‐IVIMopt50 (16‐min acquisition). 
Compared with FC‐IVIMcomp, FC‐IVIMopt25 (8‐min acqui-
sition) had a lower intersession wCV in 9 of 16 compar-
isons, with intersession wCV on average 6% higher. The 
intrasession wCV was smaller than the intersession wCV in 
only 26 of 64 comparisons (four parameters, four organs, 
four acquisition schemes).
Table 3 shows that the estimated bias in the parameter 
estimates from FC‐IVIMopt50 are smaller than the estimated 
bias in the parameter estimates from FC‐IVIMcomp.
The wCVs and ICCs at optimal setting (FC‐IVIMopt50) 
are reported in Table 4. D and f had good reliability (ICC 
≥ 0.75) in seven of eight measures and v and τ had worse 
reliability (ICC < 0.75) in all measures. This is in agree-
ment with the wCVs being generally higher for f and D. 
Table 5 shows the mean fitted parameter values and their 
standard deviation over the different volunteers (including 
the three repeated measurements) for these optimal settings 
(FC‐IVIMopt50). The spleen had lowest perfusion signal frac-
tion (Table 5: 9.3 ± 2.7 %) and poorest wCV for the perfu-
sion‐related parameters (Table 4: wCV of f is 56.7%; wCV 
of τ is 124.7%; wCV of v is 143.2%), whereas the liver had 
the highest perfusion signal fraction (45.0 ± 4.7 %) and best 
wCV for the perfusion‐related parameters (e.g., wCV of f is 
14.7%; wCV of τ is 25.2%; wCV of v is 12.5%).
4 |  DISCUSSION
We developed an acquisition protocol for FC‐IVIM in the 
abdomen with a clinically feasible scan time (8 and 16 min 
for our two suggested protocols). This was achieved by mak-
ing use of simulations to select the most informative com-
binations of b, T, and gradient shape to obtain accurate and 
F I G U R E  3  Plots of the error as a function of SNR and f for the liver (bottom) and pancreas (top) parameters. The 5%‐95% interval (light 
gray), 25%‐75% (dark gray), interval and median (black) value were plotted for the 5000 repeated simulations of the IVIMopt50 acquisition. The 
5%‐95% and 25‐75% intervals (orange dashed) and median (red dashed) values of the 5000 repeated simulations of the IVIMcomp were plotted for 
comparison
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precise FC‐IVIM DWI. We then showed that our protocol 
outperforms naive protocols of similar acquisition times in 
simulations and in abdominal scans of healthy volunteers. 
The use of our suggested protocol results in accurate and 
precise estimations of D and f, whereas the accuracy of the 
microscopic FC‐IVIM parameters v and τ was similar to the 
accuracy of D* from conventional non‐FC IVIM.16 This is 
the first study to determine the optimal scanning protocol for 
FC‐IVIM and the first which examines the test‐retest preci-
sion of FC‐IVIM parameters. Our results demonstrate the 
feasibility of implementing FC‐IVIM in clinical studies and 
provide data on precision to inform power calculations.
F I G U R E  4  Example images (after 
registration, PCA denoising, and maximum 
intensity projection) of b = 10 s/mm2 and 
b = 450 s/mm2 acquired with bipolar (left) 
and FC (right) gradients. Note that signal 
decay in vessels is less apparent in the FC 
scheme. ROIs: red, liver; green, spleen; 
blue, kidney
F I G U R E  5  Representative fits to data from all investigated acquisition approaches (FC‐IVIMopt25, FC‐IVIMopt50, FC‐IVIM100, and 
FC‐IVIMcomp) for the liver, as well as plots of data from all evaluated organs at the optimal approach FC‐IVIMopt50. The +'s indicate FC data at 
different T, for which the fit result is described by solid lines. The ×’s indicate the data from bipolar gradients at different T, for which the fit result 
is described by the overlapping dashed lines. The units of the fitted values are: D [10−3 mm2/s], f [%], τ [ms], and v [mm/s]
? ??? ??? ??? ??? ? ??? ??? ??? ??? ? ??? ??? ??? ???
? ??? ??? ??? ???? ??? ??? ??? ???? ??? ??? ??? ???
??????????????? ??????????? ??????????????????????????
????????????????????????????????????????
τ??????????????????
??????????????? ??????????? ??????????????????????????
??????????????????????????????????????????
τ?????????????????? ??????????????? ??????????? ??????????????????????????
??????????????????????????????????????
τ?????????????????? ??????????????? ??????????? ??????????????????????????
????????????????????????????????????????
τ?????????????????????
???????????? ??????????? ??????????????????????????
????????????????????????????????????????
τ???????????????? ??????????????? ??????????? ??????????????????????????
??????????????????????????????????????????
τ???????????????? ??????????????????????????????????????????
   | 9GURNEY‐CHAMPION Et Al.
We find that f is estimated at high precision, particularly 
for the liver (intersession wCV = 14.7%) and kidneys (inter-
session wCV = 14.8‐17.8%) when compared with literature 
(liver: 11.4‐34%16,28-31 median 25.3; kidney: 25‐36%32). The 
wCV of D for FC‐IVIM was similar to literature values of 
conventional IVIM (wCV D = 5‐17%16,29-33). The wCV of 
v and τ from FC‐IVIM are in a similar range as D* from con-
ventional IVIM model (e.g., 25‐194 for various abdominal 
organs16,29-33).
Recently, it was also shown in phantom measurements 
that FC‐IVIM better reflects the actual microstructure than 
conventional IVIM: only FC‐IVIM was able to estimate f 
accurately and precisely, independent of the applied blood 
flow.14 The combination of the improved description of phys-
iology, together with the improved accuracy and precision, 
Intersession FC‐IVIMopt25 FC‐IVIMopt50 FC‐IVIM100 FC‐IVIMcomp
D 12.7 11.1 11.8 15.9
f 29.2 16.3 16.0 25.5
τ 62.1 65.5 39.2 57.8
v 64.0 36.0 26.5 64.5
Intrasession
D 16.4 9.4 5.9 16.2
f 36.5 14.1 12.9 16.7
τ 83.7 71.2 30.3 62.1
v 89.0 56.2 42.4 123.9
T A B L E  2  Median (over all organs) 
intersession and intrasession wCVs (%) of 
the different fit parameters for the different 
datasets
FC‐IVIMopt50 Liver Spleen Left kidney Right kidney
D (%) −4.6 −0.4 −1.0 0.0
f (%) −1.7 0.2 −2.8 −1.9
τ (%) −1.4 16.5 −1.3 8.5
v (%) 5.0 3.0 11.6 6.0
FC‐IVIMcomp
D (%) −6.9 0.7 −1.0 −0.9
f (%) −7.8 2.1 6.3 5.0
τ (%) −15.1 9.0 −13.7 8.7
v (%) −27.1 4.2 −21.8 −11.4
T A B L E  3  Estimated bias expressed as 
mean of the % difference from FC‐IVIMopt50 
and FC‐IVIMcomp compared to FC‐IVIM100 
(Equation 6)
T A B L E  4  FC‐IVIMopt50 intersession wCVs (%; top half) and 
ICCs (bottom half) of the different organs
wCV Liver Spleen Left kidney Right kidney
D 17.2 10.1 12.2 9.0
f 14.7 56.7 14.8 17.8
τ 25.2 124.7 71.3 59.7
v 12.5 143.2 25.8 46.1
ICC
D 0.75 0.92 0.79 0.81
f 0.90 0.46 0.88 0.77
τ 0.50 n.a. 0.57 0.40
v 0.74 n.a. 0.70 0.63
Note: that the ICC of τ and v were negative for the spleen due to a large within‐
subject variability and hence are unreliable (n.a.).
T A B L E  5  Mean parameter values ± standard deviation (SD) over the volunteers using our optimized FC‐IVIMopt50 protocol
FC‐IVIMopt50
Liver Spleen Left kidney Right kidney
Mean SD Mean SD Mean SD Mean SD
D (10−3 mm2/s) 1.61 ±0.16 0.84 ±0.07 2.30 ±0.16 2.36 ±0.14
f (%) 45.0 ±4.7 9.3 ±2.7 19.4 ±1.9 19.6 ±2.3
τ (ms) 171 ±19 147 ±54 71 ±22 71 ±19
v (mm/s) 8.4 ±0.6 5.9 ±2.8 10.8 ±1.5 10.8 ±2.1
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clearly highlights the potential advantages of FC‐IVIM over 
conventional IVIM.
To find the optimal acquisition in the simulations, all er-
rors were deemed equally important. Therefore, the added 
acquisitions mainly focused on reducing the error in the pa-
rameters with the largest errors, i.e., τ and v, whereas the er-
rors in D and f decreased slower (Figure 2). One could add 
weights to the different parameters when determining the 
overall error in the simulation to focus on optimizing the 
sequence for certain parameters. As FC‐IVIM has not been 
investigated in patients and hence clinically relevant effect‐
size is unknown, it is unclear whether these values are clini-
cally sufficient or whether certain parameters should receive 
higher weights during optimization.
We focused on abdominal imaging; however, we believe 
our methods and results can be useful for other tissue too. 
Our simulations were performed for a broad range of tissue 
parameters to ensure our protocol was not optimized to a very 
specific parameter value. Organs with tissue properties that 
fall within this range should also benefit from the optimized 
protocol too. The brain generally has a lower perfusion frac-
tion (f~5%) than our simulation range,34 as well as typically 
higher SNR. To find optimal settings in brain MRI, simula-
tions could be repeated with different settings.
FC‐IVIM performs better at higher perfusion fractions. 
This is initially shown in our simulations (Figure 3) and 
confirmed in our in vivo data. In vivo, the ROI with highest 
f, the liver (f = 45.0 ± 4.7%), had overall best precision for 
the perfusion‐related parameters and the ROI with lowest 
f, the spleen (f = 9.3 ± 2.7%), had overall worst precision for 
the perfusion‐related parameters. Furthermore, our simula-
tions suggest that higher SNR increases the performance. We 
would, therefore, suggest initially implementing FC‐IVIM 
clinically in well‐perfused organs with high SNR.
As the intrasession wCV is only affected by short‐term (< 
60 min) variations in the parameters, whereas the interses-
sion wCV is additionally affected by day‐to‐day variations, 
one would expect intrasession wCV to be smaller than or 
equal to the intersession wCV. There are several explanations 
why, for our dataset, the intrasession wCV was similar to the 
intersession wCV. Long‐term biological variations could be 
smaller than short‐term variations for the diffusion and per-
fusion processes measured, resulting in similar wCVs, both 
dominated by the short‐term contribution. Furthermore, the 
general measurement accuracy could be of the order of the 
long‐term and short‐term biological variations, and hence 
dominate the uncertainty in both cases. Finally, the sample 
size of volunteers could be too small to detect differences 
between intersession wCV and intrasession wCV.
There is still debate on the use of motion management 
in IVIM, with conflicting advice.31,35 This is reflected in 
the ISMRM consensus on DWI outside the brain, where for 
IVIM “a free‐breathing or respiratory‐triggered” protocol is 
advised.36 As our purpose was to compare the optimized se-
quence to a nonoptimized complementary sequence, many 
diffusion‐weightings (100 for intersession, 200 for intrases-
sion) had to be obtained per session. To achieve this within 
a single scan session, no respiratory motion management 
was performed. We have taken multiple steps in minimizing 
the effect of motion and believe it did not influence our re-
sults. We performed image registration to ensure images are 
aligned. Furthermore, most of our gradients were FC gradi-
ents that are typically used in cardiac imaging for their motion 
robustness.37 Moreover, we had slice gaps to prevent inflow 
of excited blood and cross‐talk between slices. Finally, we 
used PCA and maximum intensity projection24 to correct for 
any remaining motion‐related signal dropout.
In this study, FC‐IVIM fits were performed ROI‐wise, 
whereas voxel‐wise fits might be preferred for clinical ap-
plications. With the current implementation, voxel‐wise 
fits take long (seconds per voxel) and are susceptible to 
noise and partial voluming effects. For conventional IVIM, 
several attempts have been made on optimizing voxel‐wise 
fits using Bayesian approaches,38,39 segmented fits,40 non‐ 
negative least squares,41 and, recently, neural‐network‐based 
fit approaches.42,43 To render future FC‐IVIM applications 
with voxel‐wise parameter estimation possible, fitting ap-
proaches with improved robustness should be investigated.
Only one study in literature has investigated FC‐IVIM 
parameters in the abdomen,13 where D = 1.12 × 10−3 
mm2/s, f = 34.7%, τ = 144 ms, and v = 4.6 mm/s were 
observed in the liver. In contrast, we observed D = 1.61 ± 
0.16 × 10−3 mm2/s, f = 20 ± 4.7%, τ = 171 ± 19 ms, and 
v = 8.4 ± 0.6 mm/s. We believe the difference in parame-
ter values might be caused by different strategies for delin-
eating the liver: Wetscherek et al13 avoided larger vessels, 
as done in conventional IVIM. In conventional IVIM, D 
ranges from 0.66‐1.50 × 10−3 mm2/s and f from 5.5‐47.1% 
in literature.44 The relatively large f that we report is a result 
of the long echo time, which decreases the signal contribu-
tion of liver tissue, with short T2 of typically 46 ± 6 ms,45 
compared with venous blood, with T2 in the order of 181 
± 23 ms.46 Assuming these T2‐values, our f would have 
been 20.3%20,47 if we had a typical TE of 50 ms. This value 
agrees well with the literature range.
For the spleen, we found a mean D of 0.84 ± 0.07 × 10−3 
mm2/s, which is in the same range as reported by Jerome et 
al, who found D = 0.91 ± 0.16 × 10−3 mm2/s in the spleens 
of 10 healthy volunteers.35 We found an f = 9.3 ± 2.7%, 
which is between the literature values of f = 7.6%35 and 
f = 12%.48 We found D = 2.30 ± 0.16 × 10−3 mm2/s and 
2.36 ± 0.14 × 10−3 mm2/s, and f = 19.4 ± 1.9% and 29.6 
± 2.3% for the left and right kidneys, respectively. These 
values are within the range of reported literature values 
in healthy volunteers of D = 1.4‐2.1 × 10−3 mm2/s and 
f = 9‐33%.32,49-51 Recently, a T2‐dependence of D was 
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reported in prostate cancer patients,52 which could point to 
our long echo times as a possible explanation why our D‐
values lay at the edges of the interval of reported literature 
values. Another factor influencing the values could be mag-
netic field strength.53
A limitation of this study was the broader fit boundar-
ies used to determine the optimal parameters. Later on in the 
research project, we found that tighter boundaries resulted 
in a more stable fit. However, volunteer data were already 
acquired with the optimal set determined with broader fit 
boundaries. By repeating the simulations (results not shown), 
we found tighter fit boundaries resulted in similar optimal 
acquisition distribution. Another limitation is the manually 
chosen initial five acquisition points. The results in figure 
1 would indicate that these acquisition points are not nec-
essarily representative of the combinations selected by the 
algorithm. Another limitation was the large slice gap (8 mm) 
we used to prevent the inflow of excited blood and crosstalk 
between slices. Potentially, interleaved scanning with longer 
TRs could overcome this limitation, but this would add sub-
stantially to the scanning time. Cross‐talk and, in particular, 
inflow of blood that was exited in previous slice acquisitions 
is a challenge in general IVIM measurements which deserves 
further investigation. Although DWI was obtained in six dif-
ferent diffusion directions, the effect of diffusion direction 
on the signal was not investigated in this study, as it is not 
considered in the FC‐IVIM model.
The FC‐IVIM protocol was only studied in young and 
healthy volunteers. To date, no FC‐IVIM protocol, including 
our 1‐h sessions, was compact enough for patient scanning. 
Our optimized protocol is now compact enough to scan in 
patients. As our protocol does not rely on requirements that 
would be different in a patient (such as the ability to follow 
breathing instructions), we believe its performance will be 
similar to the results from this work. If 8 min is still consid-
ered too long an acquisition, the optimal b‐values for shorter 
acquisitions can be deduced from Supporting Information 
Table S1 and the performance is shown in Figure 2.
5 |  CONCLUSIONS
In this study, we demonstrated the feasibility of including 
FC‐IVIM in a clinical setting to investigate changes in vas-
culature in strongly perfused organs. We have optimized the 
FC‐IVIM acquisition characterizing the accuracy (simula-
tions) and precision (simulations and in vivo experiments) of 
FC‐IVIM parameter estimates. The resulting optimized ac-
quisition strategies (FC‐IVIMopt25 and FC‐IVIMopt50) facili-
tate clinically acceptable acquisition times (8‐16 min). At the 
optimal settings, FC‐IVIM shows better test‐retest precision 
than conventional IVIM, particularly for estimating the per-
fusion fraction. FC‐IVIM is now ready to be used in clinical 
trials, to assess its value.
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